David Malcom Rodman - Net Worth and Insider Trading

David Malcom Rodman Net Worth

The estimated net worth of David Malcom Rodman is at least $2 Million dollars as of 2024-11-05. David Malcom Rodman is the Chief Medical Officer of Mineralys Therapeutics Inc and owns about 102,873 shares of Mineralys Therapeutics Inc (MLYS) stock worth over $1 Million. David Malcom Rodman is also the Exec Vice President and CMO of Alpine Immune Sciences Inc and owns about 2,842 shares of Alpine Immune Sciences Inc (ALPN) stock worth over $184,645. Details can be seen in David Malcom Rodman's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David Malcom Rodman has not made any transactions after 2024-07-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of David Malcom Rodman

To

David Malcom Rodman Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, David Malcom Rodman owns 2 companies in total, including Alpine Immune Sciences Inc (ALPN) , and Mineralys Therapeutics Inc (MLYS) .

Click here to see the complete history of David Malcom Rodman’s form 4 insider trades.

Insider Ownership Summary of David Malcom Rodman

Ticker Comapny Transaction Date Type of Owner
ALPN Alpine Immune Sciences Inc 2017-01-04 See Remarks
MLYS Mineralys Therapeutics Inc 2024-07-16 Chief Medical Officer

David Malcom Rodman Latest Holdings Summary

David Malcom Rodman currently owns a total of 2 stocks. Among these stocks, David Malcom Rodman owns 102,873 shares of Mineralys Therapeutics Inc (MLYS) as of July 16, 2024, with a value of $1 Million and a weighting of 88.3%. David Malcom Rodman also owns 2,842 shares of Alpine Immune Sciences Inc (ALPN) as of January 4, 2017, with a value of $184,645 and a weighting of 11.7%.

Latest Holdings of David Malcom Rodman

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
MLYS Mineralys Therapeutics Inc 2024-07-16 102,873 13.54 1,392,900
ALPN Alpine Immune Sciences Inc 2017-01-04 2,842 64.97 184,645

Holding Weightings of David Malcom Rodman


David Malcom Rodman Form 4 Trading Tracker

According to the SEC Form 4 filings, David Malcom Rodman has made a total of 3 transactions in Mineralys Therapeutics Inc (MLYS) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Mineralys Therapeutics Inc is the sale of 525 shares on July 16, 2024, which brought David Malcom Rodman around $7,875.

According to the SEC Form 4 filings, David Malcom Rodman has made a total of 0 transactions in Alpine Immune Sciences Inc (ALPN) over the past 5 years. The most-recent trade in Alpine Immune Sciences Inc is the sale of 1,672 shares on January 4, 2017, which brought David Malcom Rodman around $15,180.

Insider Trading History of David Malcom Rodman

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

David Malcom Rodman Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

David Malcom Rodman Ownership Network

Ownership Network List of David Malcom Rodman

No Data

Ownership Network Relation of David Malcom Rodman

Insider Network Chart

David Malcom Rodman Owned Company Details

What does Alpine Immune Sciences Inc do?

Who are the key executives at Alpine Immune Sciences Inc?

David Malcom Rodman is the See Remarks of Alpine Immune Sciences Inc. Other key executives at Alpine Immune Sciences Inc include Senior VP and CFO James Paul Rickey , director & Executive Chairman and CEO Mitchell Gold , and director & 10 percent owner Xiangmin Cui .

Alpine Immune Sciences Inc (ALPN) Insider Trades Summary

Over the past 18 months, David Malcom Rodman made no insider transaction in Alpine Immune Sciences Inc (ALPN). Other recent insider transactions involving Alpine Immune Sciences Inc (ALPN) include a net sale of 281,514 shares made by James Paul Rickey , a net sale of 213,302 shares made by Mitchell Gold , and a net sale of 1,546,347 shares made by Peter A. Thompson .

In summary, during the past 3 months, insiders sold 0 shares of Alpine Immune Sciences Inc (ALPN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 3,587,529 shares of Alpine Immune Sciences Inc (ALPN) were sold and 750,000 shares were bought by its insiders, resulting in a net sale of 2,837,529 shares.

Alpine Immune Sciences Inc (ALPN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Alpine Immune Sciences Inc Insider Transactions

No Available Data

David Malcom Rodman Mailing Address

Above is the net worth, insider trading, and ownership report for David Malcom Rodman. You might contact David Malcom Rodman via mailing address: 3122 Sterling Circle, Suite 200, Boulder Co 80301.